MITEN PATEL, MD

BIOGRAPHY

Dr. Miten Patel is board-certified in medical oncology, internal medicine, and hematology, and practices at our Southpoint location. After receiving his Bachelor of Arts with Honors in Biology in his home state of New Jersey, Dr. Patel moved to Virginia where he earned his Doctor of Medicine from Medical College of Virginia. During his final year of medical school, Dr. Patel served as the co-instructor for the Foundations of Clinical Medicine course.

From 1994-1997, Dr. Patel worked one-on-one with the 2015 Nobel Prize winner in Medicine, Dr. William C. Campbell, as a student in his lab. During this time, he co-authored several peer-reviewed journal articles and won several research awards.

The residency and fellowship programs at the University of Florida in Gainesville brought him to south to Florida, and he joined CSNF soon after their completion in 2007. In addition to serving as CSNF’s lab director, Dr. Patel has held many leadership positions at St. Vincent’s, Southside, including: President of Medical Staff, Chairman of the Department of Internal Medicine, and most recently, Chief of the Division of Hematology/Oncology. He has also served on the Board of Directors for St. Vincent’s Healthcare.

With over 15 years of experience in clinical research, including clinical trials, Dr. Patel emphasizes that an informed patient is an empowered patient. “I always strive to make sure all of my patients understand completely what their treatment will entail,” he says, “and make sure I am available with answers to any questions they may have.” He continues, “it is the understanding and confidence patients have in their care that makes all of the difference.”

When not at the office, Dr. Patel enjoys spending time with his wife and two daughters and working on his Corvette.

Curriculum Vitae

BOARD CERTIFICATIONS

Hematology
Internal Medicine
Medical Oncology

PROFESSIONAL ASSOCIATIONS

American Society of Hematology
American Society of Clinical Oncology

FELLOWSHIP

University of Florida Medical Center
Hematology/Oncology

RESIDENCY

University of Florida Medical Center

EDUCATION

Medical College of Virginia
Doctor of Medicine
Drew University
Bachelor of Arts with Honors in Biology

BOARD AND COMMITEE MEMBERSHIPS

2015 - 2017
Chief of Staff, St. Vincent’s Medical Center – Southside
2013 - 2017
Board of Directors, St. Vincent’s Healthcare
2012 - 2014
Chairman, Department of Internal Medicine, St. Vincent's Medical Center - Southside
2011 - Present
Lab Director, Southpoint, Southside and Southside Central Laboratory, Cancer Specialists, LLC
2009 - 2014
Chief, Division of Hematology & Oncology, St. Vincent’s Medical Center – Southside
2018 - Present
Chief, Division of Hematology & Oncology, St. Vincent’s Medical Center – Southside
2016 - Present
Quality Patient Safety Committee, St. Vincent’s Medical Center – Southside
2014 - Present
New Product Decision Team, St. Vincent’s Medical Center – Southside
2013 - Present
Medical Staff Executive Committee, Specialty Hospital
2012 - Present
Chairman, Medical Staff Executive Committee, St. Vincent’s Medical Center – Southside
2011 - Present
Performance Improvement Committee, Department of Medicine, Memorial Hospital
2011 - 2013
Peer Review Committee, Specialty Hospital
2011 - 2013
Peer Review Committee, Specialty Hospital
2013 - 2018
Executive Committee, Specialty Hospital
2008 - 2014
Credentials Committee, St. Vincent’s Medical Center – Southside
2009 - Present
EMR Committee, St. Vincent’s Medical Center – Southside

HONORS AND AWARDS

2014
Service of the Poor Award, St. Vincent’s Medical Center
2009
Wisdom Award, St. Vincent’s Medical Center
2001
Foundations of Clinical Medicine Teaching Award
1997
Phi Beta Kappa
1994
Beta Beta Beta, Biological Honor Society

RESEARCH (Principal Investigator Responsibilities)

NCT03371979
A Phase 1/2 study of Pegzilarginase (AEB1102-Ca-Argl-PEG) in combination with pembrolizumab in the treatment of patients with extensive disease (ED) small cell lung cancer (SCLC). Phase I/II, Interventional
NCT03400098
Expanded Access Program for Tegsedi (inotersen) (ISIS 420915) in Patients with Hereditary Transthyretin Amyloidosis (hATTR). Expanded Access
NCT02993731
A Phase III Study of BBI-608 Plus Nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma. Phase III, Interventional
NCT02923921
A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compare with FOLFOX Alone as Second-line Therapy in Patients with Metastatic Pancreatic Cancer that has Progressed During or Following a First-Line Gemcitabine Containing Regimen. Phase III, Interventional
NCT02538666
A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) after Completion of Platinum-base First Line Chemotherapy. Phase III, Interventional
NCT02200757
A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects with Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy. Phase II, Interventional
NCT01956812
An International, Multi-Center, Double-Blind, Randomized, Phase III Trial of 90Y-Clivatuzumab Tetraxetan plus Low-Dose Gemcitabine Versus Placebo plus Low-Dose Gemcitabine in Patients with Metastatic (Stage IV) Pancreatic Adenocarcinoma Who Received at Least Two Prior Treatments. Phase III, Interventional
NCT01831726
Modular Phase II Study to Link Targeted Therapy to Patients with Pathway Activated Tumors: Module 2 - Dovitinib for Patients with Tumor Pathway Activations Inhibited by Dovotonib Including Tumors with Mutations of Translocations of FGFR, PDGFR, VEGF, CKIT, FLT3, CSFR1, TRK and RET. Phase II, Interventional
NCT03500549
Study to Evaluate the Efficacy and Safety of APL-2 in Patients with PNH
NCT01831726
Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors
NCT03531255
APL-2 Long Term Safety and Efficacy Extension Study
NCT01831726
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01: "Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors

PUBLICATIONS

Lung Cancer
"ALDH1A1 and ALDH3A1 Expression in Lung Cancers: Correlation with Histologic Type and Potential Precursors"
Journal of Clinical Oncology
"Retrospective Review of State III Non-Small Lung Cancer Patients Treated With Carboplatin/Paclitaxel Plus Radiotherapy Followed by Docetaxel"
Oncology Handbook 2nd and 3rd Editions
"NSCLC, ScLC, Mesothelioma, Renal Cell Carcinoma, and Head & Neck Cancers"
Journal of Parasitology
"Inhibitory Effect of Chlorpromazine on Nematode Eggs and Larvae"
Journal of Parasitology
"Inhibitory Effect of ChlorproEnhanced Ability of Third-Stage Larvae of Haemonchus contortus to Withstand Drug Exposure after Chemically Induced Exsheathment"mazine on Nematode Eggs and Larvae"
Bios, Volume 68
"Effects of Ivermectin on Eggs and First-stage Larvae of Nematodes"